Sponsors of CNS-directed gene therapies are now being urged to embed independent imaging review
Utilizing brewery-style fermentation tanks to cultivate cocoa cells allows manufacturers to
The historical classification of the PVT1 locus as a non-coding region has been overturned by evidence showing it produces functional proteins that dictate the survival of malignant cells. For decades, the oncology community has viewed the MYC gene as the most frustrating obstacle in cancer
Hims & Hers is currently navigating a complex period of transition as it trades its historical high-margin profile for a dominant position in the weight-loss sector. Operating at a volatile crossroads where rapid corporate expansion meets intense federal oversight, the leading telehealth platform
Preliminary research indicates that artificial intelligence can identify documented medical
Utilizing a Visual-Global Relation Fusion Network enables the discovery of crucial pathological
In 2026, boards and customers are asking a direct question: can promising science be turned into reliable, affordable systems that deliver audited outcomes at scale, quarter after quarter, without…
The partnership between Eli Lilly and NVIDIA to build a supercomputer capable of running trillions
The biopharma playbook is being actively rewritten. After years of chasing breakthrough science at
The pharmaceutical sector is entering a decisive phase as obesity therapeutics gain more ground as
Advanced Therapy Medicinal Products cannot be scaled the same way biologics were. The core
Advanced algorithms are now capable of correlating visual cellular patterns on pathology slides with specific gene-expression profiles linked to aggressive disease. This breakthrough in digital pathology allows clinicians to look beyond the surface level of tissue samples to understand the
Dr. Colleen Clancy is pioneering the use of Optical Digital Twins to bridge the gap between complex
A molecule may show exceptional potency against a biological target in a test tube yet fail
